• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液α-突触核蛋白定量检测在散发性克雅氏病诊断中的实验室间验证

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease.

作者信息

Kruse Niels, Heslegrave Amanda, Gupta Vandana, Foiani Martha, Villar-Piqué Anna, Schmitz Matthias, Lehmann Sylvain, Teunissen Charlotte, Blennow Kaj, Zetterberg Henrik, Mollenhauer Brit, Zerr Inga, Llorens Franc

机构信息

Institute for Neuropathology, University Medical Center Göttingen, Göttingen, Germany.

Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK.

出版信息

Alzheimers Dement (Amst). 2018 Jul 7;10:461-470. doi: 10.1016/j.dadm.2018.06.005. eCollection 2018.

DOI:10.1016/j.dadm.2018.06.005
PMID:30294658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6171371/
Abstract

INTRODUCTION

Cerebrospinal fluid α-synuclein level is increased in sporadic Creutzfeldt-Jakob disease cases. However, the clinical value of this biomarker remains to be established. In this study, we have addressed the clinical validation parameters and the interlaboratory reproducibility by using an electrochemiluminescent assay.

METHODS

Cerebrospinal fluid α-synuclein was quantified in a total of 188 sporadic Creutzfeldt-Jakob disease and non-Creutzfeldt-Jakob-disease cases to determine sensitivity and specificity values and lot-to-lot variability. Two round robin tests with 70 additional cases were performed in six independent laboratories.

RESULTS

A sensitivity of 93% and a specificity of 96% were achieved in discriminating sporadic Creutzfeldt-Jakob disease. No differences were detected between lots. The mean interlaboratory coefficient of variation was 23%, and the intralaboratory coefficient of variations ranged 2.70%-11.39%. Overall, 97% of samples were correctly diagnosed.

DISCUSSION

The herein validated α-synuclein assay is robust, accurate, and reproducible in identifying Creutzfeldt-Jakob disease cases. Thus, it is ready for implementation in the clinical practice to support the diagnosis of Creutzfeldt-Jakob disease.

摘要

引言

散发性克雅氏病患者脑脊液中α-突触核蛋白水平升高。然而,这种生物标志物的临床价值仍有待确定。在本研究中,我们通过使用电化学发光分析法探讨了临床验证参数和实验室间的可重复性。

方法

对总共188例散发性克雅氏病和非克雅氏病病例的脑脊液α-突触核蛋白进行定量,以确定敏感性和特异性值以及批次间的变异性。在六个独立实验室对另外70例病例进行了两轮比对试验。

结果

在鉴别散发性克雅氏病方面,敏感性达到93%,特异性达到96%。批次间未检测到差异。实验室间变异系数的平均值为23%,实验室内部变异系数范围为2.70%-11.39%。总体而言,97%的样本得到了正确诊断。

讨论

本文验证的α-突触核蛋白检测方法在识别克雅氏病病例方面稳健、准确且可重复。因此,它已准备好在临床实践中应用,以辅助克雅氏病的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/6171371/5ce511f66725/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/6171371/dd29abbadb72/gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/6171371/48b4f4e55f8d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/6171371/c78c27e66c06/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/6171371/5ce511f66725/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/6171371/dd29abbadb72/gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/6171371/48b4f4e55f8d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/6171371/c78c27e66c06/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c2c/6171371/5ce511f66725/gr4.jpg

相似文献

1
Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease.脑脊液α-突触核蛋白定量检测在散发性克雅氏病诊断中的实验室间验证
Alzheimers Dement (Amst). 2018 Jul 7;10:461-470. doi: 10.1016/j.dadm.2018.06.005. eCollection 2018.
2
High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob disease.血浆和脑脊液β-突触核蛋白对散发性克雅氏病具有较高的诊断性能。
Ann Clin Transl Neurol. 2023 Oct;10(10):1904-1909. doi: 10.1002/acn3.51873. Epub 2023 Aug 8.
3
Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease.α-突触核蛋白作为散发性克雅氏病脑脊液生物标志物的验证。
Mol Neurobiol. 2018 Mar;55(3):2249-2257. doi: 10.1007/s12035-017-0479-5. Epub 2017 Mar 21.
4
Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases.评估 α-突触核蛋白作为不同朊病毒病的新型脑脊液生物标志物。
Alzheimers Dement. 2017 Jun;13(6):710-719. doi: 10.1016/j.jalz.2016.09.013. Epub 2016 Nov 18.
5
A test for Creutzfeldt-Jakob disease using nasal brushings.使用鼻腔刷进行克雅氏病检测。
N Engl J Med. 2014 Aug 7;371(6):519-29. doi: 10.1056/NEJMoa1315200.
6
Diagnostic Utility of Cerebrospinal Fluid α-Synuclein in Creutzfeldt-Jakob Disease: A Systematic Review and Meta-Analysis.脑脊液α-突触核蛋白在克雅氏病诊断中的应用:系统评价和荟萃分析。
J Alzheimers Dis. 2022;89(2):493-503. doi: 10.3233/JAD-220425.
7
Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.脑脊髓液生物标志物支持克雅氏病和快速进行性痴呆的诊断:长达 10 年的纵向多中心研究。
Brain. 2012 Oct;135(Pt 10):3051-61. doi: 10.1093/brain/aws238. Epub 2012 Sep 25.
8
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.散发性 Creutzfeldt-Jakob 病的临床诊断标准更新版。
Brain. 2009 Oct;132(Pt 10):2659-68. doi: 10.1093/brain/awp191. Epub 2009 Sep 22.
9
Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt-Jakob Disease and Synucleinopathy.脑脊髓液总α-突触核蛋白和磷酸化α-突触核蛋白在克雅氏病和突触核蛋白病患者中的变化。
Mol Neurobiol. 2019 May;56(5):3476-3483. doi: 10.1007/s12035-018-1313-4. Epub 2018 Aug 22.
10
Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.遗传性朊病毒病的脑脊液生物标志物的诊断准确性。
Brain. 2022 Apr 18;145(2):700-712. doi: 10.1093/brain/awab350.

引用本文的文献

1
Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.遗传性朊病毒病的脑脊液生物标志物的诊断准确性。
Brain. 2022 Apr 18;145(2):700-712. doi: 10.1093/brain/awab350.
2
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease.散发性克雅氏病的生物标志物和诊断指南。
Lancet Neurol. 2021 Mar;20(3):235-246. doi: 10.1016/S1474-4422(20)30477-4.
3
Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies.人类可传播性海绵状脑病生前诊断的挑战与进展

本文引用的文献

1
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis.脑脊液 α-突触核蛋白在帕金森病中的诊断效用:系统评价和荟萃分析。
Mov Disord. 2017 Oct;32(10):1389-1400. doi: 10.1002/mds.27110. Epub 2017 Sep 7.
2
Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease.α-突触核蛋白作为散发性克雅氏病脑脊液生物标志物的验证。
Mol Neurobiol. 2018 Mar;55(3):2249-2257. doi: 10.1007/s12035-017-0479-5. Epub 2017 Mar 21.
3
Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases.
Front Bioeng Biotechnol. 2020 Oct 20;8:585896. doi: 10.3389/fbioe.2020.585896. eCollection 2020.
4
Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease.朊病毒病生物标志物在医源性克雅氏病中的诊断准确性。
Biomolecules. 2020 Feb 12;10(2):290. doi: 10.3390/biom10020290.
5
Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease.用于辅助诊断人类朊病毒病的临床实验室检测。
J Clin Microbiol. 2019 Sep 24;57(10). doi: 10.1128/JCM.00769-19. Print 2019 Oct.
评估 α-突触核蛋白作为不同朊病毒病的新型脑脊液生物标志物。
Alzheimers Dement. 2017 Jun;13(6):710-719. doi: 10.1016/j.jalz.2016.09.013. Epub 2016 Nov 18.
4
Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer's and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies.通过多反应监测对脑脊液中α-、β-和γ-突触核蛋白进行定量分析显示,阿尔茨海默病和克雅氏病患者脑脊液中这些蛋白的浓度升高,但在突触核蛋白病患者中未发现改变。
Mol Cell Proteomics. 2016 Oct;15(10):3126-3138. doi: 10.1074/mcp.M116.059915. Epub 2016 Aug 9.
5
Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS.脑脊液神经丝作为肌萎缩侧索硬化症诊断生物标志物的多中心验证
Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jul-Aug;17(5-6):404-13. doi: 10.3109/21678421.2016.1167913. Epub 2016 Apr 11.
6
Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.脑脊液生物标志物(分析前)变异性对阿尔茨海默病诊断的影响
J Alzheimers Dis. 2016;51(1):97-106. doi: 10.3233/JAD-150953.
7
Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia.比较分析脑脊液生物标志物在神经退行性痴呆鉴别诊断中的作用。
Alzheimers Dement. 2016 May;12(5):577-89. doi: 10.1016/j.jalz.2015.10.009. Epub 2015 Dec 21.
8
MDS clinical diagnostic criteria for Parkinson's disease.帕金森病的MDS临床诊断标准。
Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424.
9
A Practical Guide to Immunoassay Method Validation.免疫分析方法验证实用指南。
Front Neurol. 2015 Aug 19;6:179. doi: 10.3389/fneur.2015.00179. eCollection 2015.
10
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.采用质谱法对脑脊液中淀粉样蛋白-β 1-42 进行定量的轮次测试。
Alzheimers Dement. 2016 Jan;12(1):55-9. doi: 10.1016/j.jalz.2015.06.1890. Epub 2015 Jul 21.